首页> 外文期刊>Parkinson’s Disease >Polysomnographic Features of Sleep Disturbances and REM Sleep Behavior Disorder in the Unilateral 6-OHDA Lesioned Hemiparkinsonian Rat
【24h】

Polysomnographic Features of Sleep Disturbances and REM Sleep Behavior Disorder in the Unilateral 6-OHDA Lesioned Hemiparkinsonian Rat

机译:单侧6-OHDA损伤的半帕金森病大鼠的睡眠障碍和REM睡眠行为障碍的多导睡眠图特征。

获取原文
           

摘要

Sleep pattern disruption, specifically REM sleep behavior disorder (RBD), is a major nonmotor cause of disability in PD. Understanding the pathophysiology of these sleep pattern disturbances is critical to find effective treatments. 24-hour polysomnography (PSG), the gold standard for sleep studies, has never been used to test sleep dysfunction in the standard 6-OHDA lesioned hemiparkinsonian (HP) rat PD model. In this study, we recorded 24-hour PSG from normal and HP rats. Recordings were scored into wake, rapid eye movement (REM), and non-REM (NREM). We then examined EEG to identify REM periods and EMG to check muscle activity during REM. Normal rats showed higher wakefulness (70–80%) during the dark phase and lower wakefulness (20%) during the light phase. HP rats showed 30–50% sleep in both phases, less modulation and synchronization to the light schedule , and more long run lengths of wakefulness . HP rats also had more REM epochs with muscle activity than control rats . Our findings that the sleep architecture in the HP rat resembles that of PD patients demonstrate the value of this model in studying the pathophysiological basis of PD sleep disturbances and preclinical therapeutics for PD related sleep disorders including RBD.
机译:睡眠模式中断,特别是REM睡眠行为障碍(RBD),是PD致残的主要非运动原因。了解这些睡眠模式障碍的病理生理学对于找到有效的治疗方法至关重要。 24小时多导睡眠图(PSG)是睡眠研究的金标准,但从未在标准的6-OHDA损伤的半帕金森病(HP)大鼠PD模型中测试睡眠功能障碍。在这项研究中,我们记录了正常和HP大鼠的24小时PSG。记录分为唤醒,快速眼动(REM)和非快速眼动(NREM)。然后,我们检查了脑电图以识别快速眼动时期,并检查了肌电图以检查快速眼动期间的肌肉活动。正常大鼠在黑暗阶段表现出较高的清醒度(70–80%),在明亮阶段表现出较低的清醒度(20%)。高压大鼠在两个阶段均表现出30%至50%的睡眠,对轻度时间表的调节和同步性较低,并且较长的清醒时间。 HP组大鼠的REM活动次数也多于对照组。我们的发现HP大鼠的睡眠结构类似于PD患者的睡眠结构,证明了该模型在研究PD睡眠障碍的病理生理基础和PD相关睡眠障碍(包括RBD)的临床前治疗方法方面的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号